Second Wave Iran Energy Shock Looms as Markets Pause
Global oil inventories are near eight-year lows as tensions around Iran raise the risk of supply disruption. Prices h...
Volatility Reduction With Index Funds
A simple approach to reducing volatility is using broad-market index funds. This intro outlines why it works and how to implement it.
23,121 articles
ChatGPT Claude Models Split on XRP Hitting $3 by Q4
Two AI models clash on XRP's path to $3 by Q4 as regulatory, liquidity, and macro factors shape divergent bets from t...
Vanguard’s 8-For-1 Split Made Tech Income Cheaper for Retirees
Vanguard’s 8-for-1 split lowered VGT’s price, letting smaller investors pursue income strategies through covered call...
What Best Quantum Computing Stocks to Own in 10 Years
Quantum computing is entering a new era of investment potential. This guide breaks down how to pick what best quantum...
Bionano (BNGO) 2026 Earnings Outlook for Investors
Investors are watching Bionano Genomics as the company enters 2026 with evolving demand for optical genome mapping. T...
Putin Running Money Wage Pressures Weigh on War Budget
Ukraine’s drone strikes on Russian supply lines intensify funding strains as deficits widen and reserves shrink. This...
Longtime Bitcoin Advocate Says MicroStrategy Could Hit $1,000
A longtime bitcoin advocate says MicroStrategy is a leveraged proxy for Bitcoin, and could trade at $1,000 per share ...
Here Group (HERE) 2026 Q3 Earnings: Key Takeaways & Tips
Here Group's Q3 2026 earnings reveal where the company is growing and where risks lurk. This article breaks down the ...
Dividend Safety Check: International Yields Under Review
Investors chase international dividend income, but IDV's 6-7% yield sits beside volatile cycles in oil, banks, and mi...
Billion Reasons (And Counting) Why Apple Stock Rules
Apple stock has turned heads for years with strong profitability and a steady drip of shareholder rewards. This artic...
Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Vertex Paying 102% Premium: Is the Crinetics Deal Worth It?
Vertex is pursuing Crinetics with a substantial all-cash offer. This deep dive breaks down what the $10 billion bid m...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status